Federica O’Brien
Director/Board Member chez TELA BIO, INC.
Fortune : 35 551 $ au 31/03/2024
Profil
Federica O’Brien currently works at TELA Bio, Inc., as Independent Director from 2019, MacroGenics, Inc., as Independent Director from 2021, and CFO'Brien Consulting LLC, as President from 2018.
Ms. O’Brien also formerly worked at GT Biopharma, Inc., as Director in 2018, Tucows, Inc., as Controller & Director-Financial Reporting, RSM US LLP, as Director-Life Sciences from 2010 to 2011, RSM McGladrey, Inc., as Director-Life Sciences, Barrier Therapeutics, Inc., as Corporate Controller, CardioKine, Inc., as Chief Financial Officer & Vice President-Finance from 2005 to 2009, Coopers & Lybrand LLP, as Audit Manager, Lucina Health, Inc., as Chief Financial & Operating Officer from 2011 to 2013, Complexa, Inc., as Chief Financial Officer from 2015 to 2017, and Avalo Therapeutics, Inc., as Chief Financial Officer, Secretary & Treasurer from 2013 to 2015.
Ms. O’Brien received her undergraduate degree from Rutgers State University of New Jersey.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TELA BIO, INC.
0,03% | 01/06/2023 | 6 270 ( 0,03% ) | 35 551 $ | 31/03/2024 |
MACROGENICS, INC.
-.--% | 22/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Federica O’Brien
| Sociétés | Poste | Début |
|---|---|---|
| TELA BIO, INC. | Director/Board Member | 13/11/2019 |
| MACROGENICS, INC. | Director/Board Member | 10/02/2021 |
| CFO'Brien Consulting LLC | President | 01/01/2018 |
Anciens postes connus de Federica O’Brien
| Sociétés | Poste | Fin |
|---|---|---|
| GT BIOPHARMA, INC. | Director/Board Member | 02/07/2018 |
Complexa, Inc.
 Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Director of Finance/CFO | 01/12/2017 |
| AVALO THERAPEUTICS, INC. | Director of Finance/CFO | 01/05/2015 |
Lucina Health, Inc.
 Lucina Health, Inc. Electronic Equipment/InstrumentsElectronic Technology Lucina Health, Inc. engages in the provision of maternity analytics platform solutions. It focuses on women at-risk of preterm birth. The company was founded by Michael G. Ross, Rosalyn P. Baxter-Jones, Kevin L. Bramer, and Dean Koch in 2008 and is headquartered in Louisville, KY. | Director of Finance/CFO | 01/04/2013 |
RSM US LLP
 RSM US LLP Miscellaneous Commercial ServicesCommercial Services RSM US LLP engages in the provision of accounting services. It offers audit, tax, consulting, and wealth management services. The firm serves the energy, government, life sciences, manufacturing, private equity, and real estate and construction industries. The company was founded by Ira B. McGladrey in 1926 and is headquartered in Chicago, IL. | Corporate Officer/Principal | 01/05/2011 |
Formation de Federica O’Brien
| Rutgers State University of New Jersey | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| GT BIOPHARMA, INC. | Health Technology |
| TUCOWS INC. | Technology Services |
| TELA BIO, INC. | Health Technology |
| MACROGENICS, INC. | Health Technology |
| AVALO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Barrier Therapeutics, Inc.
 Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Health Technology |
CardioKine, Inc.
 CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Health Technology |
| Coopers & Lybrand LLP | Commercial Services |
RSM US LLP
RSM US LLP Miscellaneous Commercial ServicesCommercial Services RSM US LLP engages in the provision of accounting services. It offers audit, tax, consulting, and wealth management services. The firm serves the energy, government, life sciences, manufacturing, private equity, and real estate and construction industries. The company was founded by Ira B. McGladrey in 1926 and is headquartered in Chicago, IL. | Commercial Services |
RSM McGladrey, Inc.
 RSM McGladrey, Inc. Miscellaneous Commercial ServicesCommercial Services RSM McGladrey, Inc. provides financial services. It offers audit, tax, consulting, financial advisory, risk advisory, technology and management, transaction advisory, wealth management. The company was founded by George Hansen and Keith Dunn in 1926 and is headquartered in Minneapolis, MN. | Commercial Services |
Lucina Health, Inc.
Lucina Health, Inc. Electronic Equipment/InstrumentsElectronic Technology Lucina Health, Inc. engages in the provision of maternity analytics platform solutions. It focuses on women at-risk of preterm birth. The company was founded by Michael G. Ross, Rosalyn P. Baxter-Jones, Kevin L. Bramer, and Dean Koch in 2008 and is headquartered in Louisville, KY. | Electronic Technology |
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Health Technology |
| CFO'Brien Consulting LLC |
